challenges in targeting krasg12c mutations
Published 2 years ago • 158 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:10
targeting non-g12c kras mutations in nsclc
-
1:25
challenges of kras-targeting for lung cancer therapy
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
1:37
treatment strategies for kras-mutant nsclc with co-mutations
-
1:59
phase i a study evaluating gdc-6036 monotherapy in patients with nsclc with kras g12c mutation
-
3:20
history of kras-targeting in clinical trials
-
4:06
amg 510 for targeting kras g12c mutant solid tumours
-
5:14
real-world outcomes by co-mutation status in kras g12c-mutant nsclc
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc
-
0:57
sotorasib: first targeted approval for kras g12c mutated nsclc
-
1:42
treating kras g12c mutations
-
5:16
mitigating resistance in kras-driven cancers
-
2:12
advances in the management of kras-mutant nsclc
-
0:41
unmet needs in kras-driven non-small cell lung cancer
-
7:51
kras g12c inhibition in advanced nsclc: amg 510
-
0:58
kras g12c inhibitors for gi cancer
-
1:01
krystal-1: adagrasib with cetuximab in kras g12c-mutated crc
-
2:04
identification and targeting of rare genomic alterations in metastatic crc